Align aspartate kinase (EC 2.7.2.4) (characterized)
to candidate 18052 b4024 aspartate kinase III (NCBI)
Query= BRENDA::P08660 (449 letters) >FitnessBrowser__Keio:18052 Length = 449 Score = 860 bits (2222), Expect = 0.0 Identities = 449/449 (100%), Positives = 449/449 (100%) Query: 1 MSEIVVSKFGGTSVADFDAMNRSADIVLSDANVRLVVLSASAGITNLLVALAEGLEPGER 60 MSEIVVSKFGGTSVADFDAMNRSADIVLSDANVRLVVLSASAGITNLLVALAEGLEPGER Sbjct: 1 MSEIVVSKFGGTSVADFDAMNRSADIVLSDANVRLVVLSASAGITNLLVALAEGLEPGER 60 Query: 61 FEKLDAIRNIQFAILERLRYPNVIREEIERLLENITVLAEAAALATSPALTDELVSHGEL 120 FEKLDAIRNIQFAILERLRYPNVIREEIERLLENITVLAEAAALATSPALTDELVSHGEL Sbjct: 61 FEKLDAIRNIQFAILERLRYPNVIREEIERLLENITVLAEAAALATSPALTDELVSHGEL 120 Query: 121 MSTLLFVEILRERDVQAQWFDVRKVMRTNDRFGRAEPDIAALAELAALQLLPRLNEGLVI 180 MSTLLFVEILRERDVQAQWFDVRKVMRTNDRFGRAEPDIAALAELAALQLLPRLNEGLVI Sbjct: 121 MSTLLFVEILRERDVQAQWFDVRKVMRTNDRFGRAEPDIAALAELAALQLLPRLNEGLVI 180 Query: 181 TQGFIGSENKGRTTTLGRGGSDYTAALLAEALHASRVDIWTDVPGIYTTDPRVVSAAKRI 240 TQGFIGSENKGRTTTLGRGGSDYTAALLAEALHASRVDIWTDVPGIYTTDPRVVSAAKRI Sbjct: 181 TQGFIGSENKGRTTTLGRGGSDYTAALLAEALHASRVDIWTDVPGIYTTDPRVVSAAKRI 240 Query: 241 DEIAFAEAAEMATFGAKVLHPATLLPAVRSDIPVFVGSSKDPRAGGTLVCNKTENPPLFR 300 DEIAFAEAAEMATFGAKVLHPATLLPAVRSDIPVFVGSSKDPRAGGTLVCNKTENPPLFR Sbjct: 241 DEIAFAEAAEMATFGAKVLHPATLLPAVRSDIPVFVGSSKDPRAGGTLVCNKTENPPLFR 300 Query: 301 ALALRRNQTLLTLHSLNMLHSRGFLAEVFGILARHNISVDLITTSEVSVALTLDTTGSTS 360 ALALRRNQTLLTLHSLNMLHSRGFLAEVFGILARHNISVDLITTSEVSVALTLDTTGSTS Sbjct: 301 ALALRRNQTLLTLHSLNMLHSRGFLAEVFGILARHNISVDLITTSEVSVALTLDTTGSTS 360 Query: 361 TGDTLLTQSLLMELSALCRVEVEEGLALVALIGNDLSKACGVGKEVFGVLEPFNIRMICY 420 TGDTLLTQSLLMELSALCRVEVEEGLALVALIGNDLSKACGVGKEVFGVLEPFNIRMICY Sbjct: 361 TGDTLLTQSLLMELSALCRVEVEEGLALVALIGNDLSKACGVGKEVFGVLEPFNIRMICY 420 Query: 421 GASSHNLCFLVPGEDAEQVVQKLHSNLFE 449 GASSHNLCFLVPGEDAEQVVQKLHSNLFE Sbjct: 421 GASSHNLCFLVPGEDAEQVVQKLHSNLFE 449 Lambda K H 0.320 0.135 0.376 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 718 Number of extensions: 16 Number of successful extensions: 1 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 449 Length of database: 449 Length adjustment: 33 Effective length of query: 416 Effective length of database: 416 Effective search space: 173056 Effective search space used: 173056 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 51 (24.3 bits)
Align candidate 18052 b4024 (aspartate kinase III (NCBI))
to HMM TIGR00656 (aspartate kinase, monofunctional class (EC 2.7.2.4))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR00656.hmm # target sequence database: /tmp/gapView.10405.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR00656 [M=407] Accession: TIGR00656 Description: asp_kin_monofn: aspartate kinase, monofunctional class Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 8.2e-158 511.6 0.1 9.3e-158 511.4 0.1 1.0 1 lcl|FitnessBrowser__Keio:18052 b4024 aspartate kinase III (NCBI Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__Keio:18052 b4024 aspartate kinase III (NCBI) # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 511.4 0.1 9.3e-158 9.3e-158 2 406 .. 3 449 .] 2 449 .] 0.97 Alignments for each domain: == domain 1 score: 511.4 bits; conditional E-value: 9.3e-158 TIGR00656 2 eliVqKFGGtsvgsserikkaakivlkelkegkkvvVVvSAmskvtdelvelae.............llkll....... 60 e++V+KFGGtsv+++++++++a+ivl++ ++ ++VV+SA++++t+ lv+lae +++++ lcl|FitnessBrowser__Keio:18052 3 EIVVSKFGGTSVADFDAMNRSADIVLSD---ANVRLVVLSASAGITNLLVALAEglepgerfekldaIRNIQfailerl 78 89*************************9...9*****************************999999666666677777 PP TIGR00656 61 ...eaisdei..................sprerdelvsvGEllssallssalrelgvkaealdgkeagilTddefgnAk 118 ++i++ei sp+ +delvs+GEl+s+ l++++lre++v+a+++d ++++++T+d+fg+A+ lcl|FitnessBrowser__Keio:18052 79 rypNVIREEIerllenitvlaeaaalatSPALTDELVSHGELMSTLLFVEILRERDVQAQWFD-VRKVMRTNDRFGRAE 156 8888888888999999999999999999***********************************.9************** PP TIGR00656 119 ikelate....erLlelLeegiivvvaGFiGateeGeiTtLGRGGSDltAallaaalkAdrveiyTDVeGvyttDPrvv 193 ++++a++ +Ll++L+eg +v+++GFiG++++G++TtLGRGGSD+tAalla+al+A+rv+i+TDV+G+yttDPrvv lcl|FitnessBrowser__Keio:18052 157 PDIAALAelaaLQLLPRLNEG-LVITQGFIGSENKGRTTTLGRGGSDYTAALLAEALHASRVDIWTDVPGIYTTDPRVV 234 *****9989999*********.9******************************************************** PP TIGR00656 194 eeakkidkisyeEalelAtlGakvlhpralelaveakvpilvrsskeke.egTlitnkkensslvkaialeknvarltv 271 ++ak+id+i+++Ea+e+At+Gakvlhp++l +av++++p++v ssk+++ gTl++nk+en++l++a+al++n+++lt+ lcl|FitnessBrowser__Keio:18052 235 SAAKRIDEIAFAEAAEMATFGAKVLHPATLLPAVRSDIPVFVGSSKDPRaGGTLVCNKTENPPLFRALALRRNQTLLTL 313 *************************************************99**************************** PP TIGR00656 272 egegmlgkrgilaeifkaLaeeeinvdlisqtesetsislvvdeedvdeakkaLkeesgaae...lesleveedlavvs 347 ++ +ml++rg+lae+f++La+++i+vdli+++e +s++l++d+++++++ ++L ++s+++e l+++evee+la+v+ lcl|FitnessBrowser__Keio:18052 314 HSLNMLHSRGFLAEVFGILARHNISVDLITTSE--VSVALTLDTTGSTSTGDTLLTQSLLMElsaLCRVEVEEGLALVA 390 ******************************999..***************************999************** PP TIGR00656 348 ivgaglveapGvaseifkaleekninilmisssetkisvlvdekdaekavrklheklee 406 ++g++l++a+Gv +e+f +le++ni+++++++s++++++lv+++dae++v+klh++l+e lcl|FitnessBrowser__Keio:18052 391 LIGNDLSKACGVGKEVFGVLEPFNIRMICYGASSHNLCFLVPGEDAEQVVQKLHSNLFE 449 *******************************************************9975 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (407 nodes) Target sequences: 1 (449 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 12.11 // [ok]
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory